Recent Insider Activity Could Benefit Tango Therapeutics Inc (TNGX)

Roman Campbell

Tango Therapeutics Inc’s filing revealed that its 10% Owner Third Rock Ventures IV, L.P. unloaded Company’s shares for reported $4.85 million on Oct 23 ’25. In the deal valued at $10.15 per share,477,401 shares were sold. As a result of this transaction, Third Rock Ventures IV, L.P. now holds 13,386,574 shares worth roughly $107.09 million.

Then, Third Rock Ventures IV, L.P. bought 477,401 shares, generating $3,594,830 in total proceeds.

Before that, Third Rock Ventures IV, L.P. sold 500,000 shares. Tango Therapeutics Inc shares valued at $4,008,500 were divested by the 10% Owner at a price of $8.02 per share. As a result of the transaction, Third Rock Ventures IV, L.P. now holds 13,863,975 shares, worth roughly $110.91 million.

Wolfe Research initiated its Tango Therapeutics Inc [TNGX] rating to a Peer perform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid August with a ‘”an Overweight”‘ rating. Jefferies began covering TNGX with “Buy” recommendation on July 17, 2024. Cantor Fitzgerald started covering the stock on April 04, 2024. It rated TNGX as “an Overweight”.

Price Performance Review of TNGX

On Tuesday, Tango Therapeutics Inc [NASDAQ:TNGX] saw its stock jump 0.25% to $8.0. Over the last five days, the stock has lost -4.53%. Tango Therapeutics Inc shares have risen nearly 104.08% since the year began. Nevertheless, the stocks have risen 158.90% over the past one year. While a 52-week high of $9.70 was reached on 10/16/25, a 52-week low of $1.03 was recorded on 05/08/25.

Levels Of Support And Resistance For TNGX Stock

The 24-hour chart illustrates a support level at 7.76, which if violated will result in even more drops to 7.52. On the upside, there is a resistance level at 8.17. A further resistance level may holdings at 8.34.

How much short interest is there in Tango Therapeutics Inc?

A steep rise in short interest was recorded in Tango Therapeutics Inc stocks on 2025-10-31, dropping by -4.42 million shares to a total of 29.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 33.81 million shares. There was a decline of -15.05%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on February 12, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $18 price target.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.